For the quarter ended October 2025, Phreesia (PHR) reported revenue of $120.33 million, up 12.7% over the same period last year. EPS came in at $0.10, compared to -$0.25 in the year-ago quarter.
The reported revenue represents a surprise of +0.17% over the Zacks Consensus Estimate of $120.13 million. With the consensus EPS estimate being $0, the company has not delivered EPS surprise.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Phreesia performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Average healthcare services Clients: 4,520 versus 4,530 estimated by three analysts on average.
- Patient payment volume: $1.18 billion versus $1.16 billion estimated by three analysts on average.
- Payment facilitator volume percentage: 85% versus the two-analyst average estimate of 81.3%.
- Revenus- Subscription and related services: $55.48 million versus the five-analyst average estimate of $55.44 million. The reported number represents a year-over-year change of +12.4%.
- Revenus- Network solutions: $37.43 million versus the five-analyst average estimate of $37.46 million. The reported number represents a year-over-year change of +14.4%.
- Revenus- Payment processing fees: $27.42 million versus $27.25 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +11% change.
View all Key Company Metrics for Phreesia here>>>
Shares of Phreesia have returned -7.9% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Phreesia, Inc. (PHR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
